An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT01664598 · COMPLETED
Trial details
- NCT number
- NCT01664598
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2015-06-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.